Scinai Immunotherapeutics (SCNI) Revenue (2024 - 2026)
Scinai Immunotherapeutics (SCNI) reported Revenue of $489000.0 for Q1 2026, down 16.55% on a YoY basis from $586000.0 in Q1 2025, and up 161.5% sequentially from $187000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Revenue (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 3 years of Revenue data on file, last reported at $489000.0 in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 16.55% year-over-year to $489000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (changed N/A YoY), and the FY2025 full-year result was $2.4 million, up 263.07% from the prior year.
- Revenue advanced to $489000.0 in Q1 2026, from $187000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $586000.0 in Q1 2025 to a low of $168000.0 in Q3 2024.
- A 3-year average of $327200.0 and a median of $206000.0 in 2024 frame the typical range for Revenue.
- Peak annual rise in Revenue reached 16.55% in 2026, while the deepest fall reached 16.55% in 2026.
- Tracing SCNI's Revenue over 3 years: stood at $206000.0 in 2024, then fell by 9.22% to $187000.0 in 2025, then surged by 161.5% to $489000.0 in 2026.
- Business Quant data shows SCNI's Revenue at $489000.0 in Q1 2026, $187000.0 in Q2 2025, and $586000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.54 Bn | 424.15 Mn | -1.12 Mn | 489,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489,000.00 |
| Jun 30, 2025 | 187,000.00 |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 206,000.00 |
| Sep 30, 2024 | 168,000.00 |